Investigating the DNa methylation profile of e-cigarette use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Richmond (2021)
E-Cigarette Flavoring Chemicals Induce Cytotoxicity in hepG2 Cells.
Nonclinical
Cyototoxicity
Rickard (2021)
Mental health problems and initiation of e-cigarette and combustible cigarette use.
Population Clinical
Consumer Use
Reasons For Use
Riehm (2019)
E-cigarette vapor decreases cellular proliferation through nicotine-dependent mechanisms.
Nonclinical
Genotoxicity
In Vitro
Rigg (2019)
Electronic vapor product usage and substance use risk behaviors among U.S. high school students.
Population Clinical
Consumer Use
Youth Use & Appeal
Rigsby (2019)
Oral nicotine pouches with an aftertaste? Part 2: in vitro toxicity in human gingival fibroblasts.
Non-Clinical
Cytotoxicity
In Vitro
Rinaldi (2023)
Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in Sh-SY5Y cells
Nonclinical
Toxicity
Riveles (2008)
Factors associated With E-Cigarette Usage and the Reasons for Initiation among Malaysian adolescents.
Population Clinical
Consumer Use
Reasons For Use
Robert Lourdes (2019)
a qualitative analysis of electronic nicotine delivery systems (ENDS) uptake and use among young adult never-smokers in New Zealand.
Population Clinical
Consumer Use
Youth Use & Appeal
Robertson (2022)
a qualitative analysis of the Experiences of People Who Resumed Smoking Following Exclusive Electronic Nicotine Delivery Systems Use.
Population Clinical
Likelihood Of Use
Former Smokers Switching From ENDS To Tobacco Products
Robertson (2023)